Accessibility Menu
Orion Oyj logo

Orion Oyj(OTC) ORINY

Current Price$43.02
Market Cap$9.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+246%
5 Year+137%
1 Year+6%
1 Month+11%
Orion Oyj last closing stock price
MetricPriceDate
Last closeUSD 43.022026-07-23
Orion Oyj stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+11.61%USD 38.542026-07-16
1 month+10.7%USD 38.862026-06-23
3 month+14.8%USD 37.472026-04-24
Year to date+18.37%USD 36.342025-12-29
1 year+6.35%USD 40.452025-07-23
3 year+120.04%USD 19.552023-07-24
5 year+136.64%USD 18.182021-07-16
Since inception+246.07%USD 12.432014-12-09

Orion Oyj Financials at a Glance

Market Cap

$9.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.06B

Net Income (TTM)

€586.88M

EPS (TTM)

$2.43

P/E Ratio

17.70

Dividend

$0.99

Beta (Volatility)

-0.05 (Low)

Price

$43.02

Volume

23

Open

$43.22

Previous Close

$43.02

Daily Range

$43.02 - $43.22

52-Week Range

$30.89 - $43.22

Estimated Earnings Date

Feb 4, 2026

ORINY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orion Oyj

Orion Oyj is a Finnish pharmaceutical company focused on developing, producing, and marketing medicines for human and animal health. The company operates in various international markets, offering a diverse range of products, including prescription medications and over-the-counter healthcare solutions.

Products and Services
  • Prescription medications for various health conditions
  • Over-the-counter healthcare solutions
  • Veterinary medications and active pharmaceutical ingredients (APIs)
Growth Outlook
  • Strong revenue growth with Q1 2026 revenue of €417.7 million
  • Net income increased to €90.4 million in Q1 2026
  • Strategic partnerships enhancing product offerings and market reach
Financial Highlights
  • Trailing twelve months (TTM) revenue of €2.5 billion
  • Net profit margin of 27.12% for the TTM period
  • Dividend yield of 2.29% with consistent payouts
Orion Oyj has established a solid foundation in the pharmaceutical industry, with a focus on innovation and quality. The company's diverse product portfolio addresses various health needs, from chronic diseases to veterinary care. Recent financial performance indicates a robust growth trajectory, with significant revenue and net income figures reflecting operational efficiency and market demand. The strategic alliances with other healthcare entities further position Orion Oyj for future growth, enhancing its ability to deliver innovative solutions to a broad customer base. The company's commitment to research and development ensures a continuous pipeline of new products, catering to evolving healthcare needs.
AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

4,235

CEO

Aino Anna Liisa Hurme, PhD

Website

www.orionpharma.com

Headquarters

Espoo, UU 02200, FI

ORINY Financials

Key Financial Metrics (TTM)

Gross Margin

65.93%

Operating Margin

35.97%

Net Income Margin

28.54%

Return on Equity

50.02%

Return on Capital

39.73%

Return on Assets

31.34%

Earnings Yield

5.65%

Dividend Yield

2.31%

Payout Ratio

41.34%

Stock Overview

Market Cap

$9.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

218.99M

Volume

23

Avg. Volume

200.677

Financials (TTM)

Gross Profit

€1.36B

Operating Income

€738.33M

EBITDA

€769.79M

Operating Cash Flow

€473.95M

Capital Expenditure

-€89.40M

Free Cash Flow

€384.77M

Cash & ST Invst.

€130.20M

Total Debt

€132.65M

Orion Oyj Performance Analysis

Orion Oyj annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,401,264,05614.1%
20232023-12-31EUR 1,287,933,018-8.1%
20242024-12-31EUR 1,667,318,13229.5%
20252025-12-31EUR 2,130,529,45527.8%
Orion Oyj sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.3%
Q42025-12-3164.9%
Q12026-03-31-39.9%
Q22026-06-3024.9%
Orion Oyj annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.3160.3%
20232023-12-31EUR 0.83-36.1%
20242024-12-31EUR 1.2752.1%
20252025-12-31EUR 2.0158.1%
Orion Oyj sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-42.4%
Q42025-12-31173.5%
Q12026-03-31-65.6%
Q22026-06-3056.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€521.60M

+25.2%

Gross Profit

€339.90M

+36.8%

Gross Margin

65.16%

N/A

Market Cap

$9.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.39M

N/A

Employees

3,943

N/A

Net Income

€140.20M

+69.9%

EBITDA

€176.50M

+68.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€130.20M

-29.1%

Total Debt

€132.65M

-64.5%

Accounts Receivable

€542.20M

+44.6%

Inventory

€525.30M

+19.0%

Long Term Debt

€103.36M

-35.3%

Short Term Debt

€29.29M

-86.3%

Return on Assets

31.34%

N/A

Return on Invested Capital

52.15%

N/A

Free Cash Flow

€255.90M

+393.1%

Operating Cash Flow

€274.80M

+245.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBHMYSino Biopharmaceutical Limited
$12.68+0.00%
GIKLYGrifols, S.A.
$5.10+0.00%
CLPBYColoplast A/S
$6.19+2.48%
SAUHYStraumann Holding AG
$11.64-1.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About ORINY

What is the current price of Orion Oyj?

Orion Oyj is trading at $43.02 per share.

What is the 52-week range for Orion Oyj?

Over the past 52 weeks, Orion Oyj has traded between $30.89 and $43.22.

How much debt does Orion Oyj have?

As of the most recent reporting period, Orion Oyj reported total debt of €151.72M.

How much cash does Orion Oyj have on hand?

Orion Oyj reported €148.86M in cash and cash equivalents in its most recent financial results.

What is Orion Oyj’s dividend yield?

Orion Oyj currently has a dividend yield of 2.31%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services